Trials / Completed
CompletedNCT02228707
Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objectives of the study are to evaluate the safety and tolerability of multiple doses of BIIB061 administered to healthy adults. The secondary objective is to determine the multiple-dose PK profile of BIIB061 in this study population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BIIB061 | Participants receive BIIB061 |
| OTHER | Placebo | Matched placebo |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2014-08-29
- Last updated
- 2016-06-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02228707. Inclusion in this directory is not an endorsement.